新型Xa因子抑制剂依度沙班的全面心电图研究。 - Suppr

Suppr

超能文献

A thorough electrocardiogram study of edoxaban, a novel factor Xa inhibitor.

作者信息

Mendell J, Basavapathruni R, Swearingen D, Draves A, Zhang G, Morganroth J

机构信息

Daiichi Sankyo Pharma Development, Edison, NJ 08837, USA.

出版信息

J Clin Pharmacol. 2011 Aug;51(8):1241-6. doi: 10.1177/0091270010381901. Epub 2011 Jan 5.

DOI:10.1177/0091270010381901

PMID:21209229

Abstract

摘要

相似文献

A thorough electrocardiogram study of edoxaban, a novel factor Xa inhibitor.新型Xa因子抑制剂依度沙班的全面心电图研究。

J Clin Pharmacol. 2011 Aug;51(8):1241-6. doi: 10.1177/0091270010381901. Epub 2011 Jan 5.

The effects of the antiplatelet agents, aspirin and naproxen, on pharmacokinetics and pharmacodynamics of the anticoagulant edoxaban, a direct factor Xa inhibitor.抗血小板药物阿司匹林和萘普生对直接 Xa 因子抑制剂抗凝药依度沙班的药代动力学和药效学的影响。

J Cardiovasc Pharmacol. 2013 Aug;62(2):212-21. doi: 10.1097/FJC.0b013e3182970991.

Oral direct factor Xa inhibition with edoxaban for thromboprophylaxis after elective total hip replacement. A randomised double-blind dose-response study.依度沙班预防择期全髋关节置换术后血栓栓塞的口服直接因子 Xa 抑制：一项随机、双盲、剂量反应研究。

Thromb Haemost. 2010 Sep;104(3):642-9. doi: 10.1160/TH10-02-0142. Epub 2010 Jun 29.

Clinical safety, tolerability, pharmacokinetics, and pharmacodynamics of the novel factor Xa inhibitor edoxaban in healthy volunteers.新型 Xa 因子抑制剂依度沙班在健康志愿者中的临床安全性、耐受性、药代动力学和药效学。

J Clin Pharmacol. 2010 Jul;50(7):743-53. doi: 10.1177/0091270009351883. Epub 2010 Jan 15.

Pharmacokinetics, safety, and tolerability of edoxaban in end-stage renal disease subjects undergoing haemodialysis.终末期肾病血液透析患者依度沙班的药代动力学、安全性和耐受性。

Thromb Haemost. 2015 Apr;113(4):719-27. doi: 10.1160/TH14-06-0547. Epub 2015 Jan 8.

Oral anticoagulation with edoxaban. Focus on current phase III clinical development.依度沙班的口服抗凝治疗。聚焦当前 III 期临床开发。

Hamostaseologie. 2012;32(3):212-5. doi: 10.5482/HAMO-12-05-0004. Epub 2012 Jul 12.

Edoxaban effects on bleeding following punch biopsy and reversal by a 4-factor prothrombin complex concentrate.依度沙班对经皮穿刺活检后出血的影响及 4 因子凝血酶原复合物浓缩物的逆转作用。

Circulation. 2015 Jan 6;131(1):82-90. doi: 10.1161/CIRCULATIONAHA.114.013445. Epub 2014 Nov 17.

A single and multiple postprandial dose study investigating the pharmacokinetics and pharmacodynamics of edoxaban in healthy Chinese volunteers .一项在健康中国志愿者中开展的关于依度沙班餐后单剂量及多剂量给药的药代动力学和药效学研究。

Int J Clin Pharmacol Ther. 2017 Mar;55(3):256-263. doi: 10.5414/CP202737.

Evaluation of the novel factor Xa inhibitor edoxaban compared with warfarin in patients with atrial fibrillation: design and rationale for the Effective aNticoaGulation with factor xA next GEneration in Atrial Fibrillation-Thrombolysis In Myocardial Infarction study 48 (ENGAGE AF-TIMI 48).新型 Xa 因子抑制剂依度沙班与华法林治疗心房颤动患者的比较评估：心房颤动-溶栓治疗心肌梗死 48 次新一代 Xa 因子有效抗凝试验（ENGAGE AF-TIMI 48）的设计和原理。

Am Heart J. 2010 Oct;160(4):635-41. doi: 10.1016/j.ahj.2010.06.042.

Pharmacokinetics of the direct factor Xa inhibitor edoxaban and digoxin administered alone and in combination.直接因子 Xa 抑制剂依度沙班与地高辛单独及联合应用的药代动力学。

J Cardiovasc Pharmacol. 2012 Oct;60(4):335-41. doi: 10.1097/FJC.0b013e31826265b6..

引用本文的文献

Drug-Drug Interactions of 257 Antineoplastic and Supportive Care Agents With 7 Anticoagulants: A Comprehensive Review of Interactions and Mechanisms.257 种抗肿瘤和支持治疗药物与 7 种抗凝药物的药物-药物相互作用：相互作用和机制的综合评价。

Clin Appl Thromb Hemost. 2020 Jan-Dec;26:1076029620936325. doi: 10.1177/1076029620936325.

Comparative risk impact of edoxaban in the management of stroke and venous thromboembolism.依度沙班在卒中与静脉血栓栓塞管理中的比较风险影响

Ther Clin Risk Manag. 2016 Apr 26;12:667-74. doi: 10.2147/TCRM.S84608. eCollection 2016.

Pharmacokinetics and Pharmacodynamics of Edoxaban, a Non-Vitamin K Antagonist Oral Anticoagulant that Inhibits Clotting Factor Xa.依度沙班（一种抑制凝血因子Xa的非维生素K拮抗剂口服抗凝剂）的药代动力学和药效学

Clin Pharmacokinet. 2016 Jun;55(6):641-55. doi: 10.1007/s40262-015-0342-7.

Edoxaban: A Review in Deep Vein Thrombosis and Pulmonary Embolism.依度沙班：用于深静脉血栓形成和肺栓塞的治疗。

Drugs. 2015 Nov;75(17):2025-34. doi: 10.1007/s40265-015-0495-6.

Edoxaban: an update on the new oral direct factor Xa inhibitor.依度沙班：新型口服直接凝血因子Xa抑制剂的最新进展。

Drugs. 2014 Jul;74(11):1209-31. doi: 10.1007/s40265-014-0261-1.

Drug-drug interaction studies of cardiovascular drugs involving P-glycoprotein, an efflux transporter, on the pharmacokinetics of edoxaban, an oral factor Xa inhibitor.涉及 P-糖蛋白（一种外排转运蛋白）的心血管药物的药物相互作用研究对口服 Xa 因子抑制剂依度沙班的药代动力学的影响。

Am J Cardiovasc Drugs. 2013 Oct;13(5):331-42. doi: 10.1007/s40256-013-0029-0.

Edoxaban: a new oral direct factor xa inhibitor.依度沙班：一种新型口服直接因子 Xa 抑制剂。

Drugs. 2011 Aug 20;71(12):1503-26. doi: 10.2165/11595540-000000000-00000.

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验